Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC) — Stella
Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(5 sites)
China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, Guangdong
Sun yat-sen university cancer center, Guangzhou, Guangdong
The fifth Affiliated Hospital of Guangzhou Medcial University, Guangzhou, Guangdong
Tongji Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei
The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan